Evidence map›Paper›PMID 38027039›Full record

ArticleBioMed research international2023

Analysis of

Ekaterina I Semenova, Suzanna A Partevian, Marina V Shulskaya, Margarita M Rudenok, Maria V Lukashevich, Nina M Baranova, Olga B Doronina, Kseniya S Doronina, Anna V Rosinskaya, Ekaterina Y Fedotova and 4 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Decoding the therapeutic potential mechanism ofFrontiers in pharmacology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Ekaterina I SemenovaNational Research Centre "Kurchatov Institute", 2 Kurchatova Sq., 123182 Moscow, Russia.ORCID https://orcid.org/0000-0001-6145-0476
Suzanna A PartevianNational Research Centre "Kurchatov Institute", 2 Kurchatova Sq., 123182 Moscow, Russia.
Marina V ShulskayaNational Research Centre "Kurchatov Institute", 2 Kurchatova Sq., 123182 Moscow, Russia.
Margarita M RudenokNational Research Centre "Kurchatov Institute", 2 Kurchatova Sq., 123182 Moscow, Russia.
Maria V LukashevichNational Research Centre "Kurchatov Institute", 2 Kurchatova Sq., 123182 Moscow, Russia.
Nina M BaranovaPeoples' Friendship University of Russia (RUDN University), 6, Miklukho-Maklaya Str., 117198 Moscow, Russia.
Olga B DoroninaNovosibirsk State Medical University, 52, Krasnyy Ave., 630091 Novosibirsk, Russia.
Kseniya S DoroninaNovosibirsk State Medical University, 52, Krasnyy Ave., 630091 Novosibirsk, Russia.
Anna V RosinskayaState Public Health Institution Primorsk Regional Clinical Hospital No. 1, 57 Aleutskaya St., 690091 Vladivostok, Russia.
Ekaterina Y FedotovaResearch Centre of Neurology, 80, Volokolamskoye Shosse, 125367 Moscow, Russia.
Sergey N IllarioshkinResearch Centre of Neurology, 80, Volokolamskoye Shosse, 125367 Moscow, Russia.
Petr A SlominskyNational Research Centre "Kurchatov Institute", 2 Kurchatova Sq., 123182 Moscow, Russia.
Maria I ShadrinaNational Research Centre "Kurchatov Institute", 2 Kurchatova Sq., 123182 Moscow, Russia.
Anelya Kh AlievaNational Research Centre "Kurchatov Institute", 2 Kurchatova Sq., 123182 Moscow, Russia.
Kurchatov Institute · RUNovosibirsk State Medical University · RUResearch Center of Neurology · RUPeoples' Friendship University of Russia · RURegional Children's Clinical Hospital No. 1 · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a common chronic, age-related neurodegenerative disease. This disease is characterized by a long prodromal period. In this context, it is important to search for the genes and mechanisms that are involved in the development of the pathological process in the earliest stages of the disease. Published data suggest that blood cells, particularly lymphocytes, may be a model for studying the processes that occur in the brain in PD. Thus, in the present work, we performed an analysis of changes in the expression of the genes

Indexed as

Neurodegenerative DiseasesParkinson DiseaseBrainCyclooxygenase 2Gene ExpressionHumansCyclooxygenase 2PTGS2 protein, human

Identifiers

PMID38027039
PMCPMC10681775
OpenAlexW4388817817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.